Related Experiment Video
Updated: May 7, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Novel approaches in antimalarial drug discovery
Jana Held1, Andrea Kreidenweiss, Benjamin Mordmüller
1University of Tübingen, Institute of Tropical Medicine , Wilhelmstraße 27, D-72074 Tübingen , Germany +49 7071 29 82364 ; +49 7071 295189 ; janaheld@hotmail.de.
New antimalarial drug discovery is crucial due to Plasmodium falciparum resistance. Controlled human malaria infection models show promise for accelerating the development of novel antimalarial compounds.
Area of Science:
- Drug Discovery
- Parasitology
- Infectious Diseases
Background:
- Antimalarial drug resistance in Plasmodium falciparum necessitates novel therapeutic strategies.
- Existing treatments are becoming less effective, driving the need for new antimalarial drug development.
Purpose of the Study:
- To review classical and novel approaches in antimalarial drug discovery.
- To highlight methodologies for early efficacy testing of antimalarial compounds.
Main Methods:
- Literature review of antimalarial drug discovery strategies.
- Emphasis on parasite life cycle stages and Plasmodium species.
- Discussion of early efficacy testing methodologies.
Main Results:
- Recent efforts have identified promising new antimalarial drug candidates.
- Challenges remain in selecting and advancing compounds for clinical trials.
Conclusions:
- Controlled human malaria infection models can expedite early-stage drug development.
- Further research is needed to overcome roadblocks in antimalarial drug development.
Related Concept Videos
Drug Discovery: Overview
Anthelminthic Agents
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

